Persistent Asset Partners Ltd holds a diversified book of 714 stocks worth $317.0M as of Q2 2026 (disclosed Aug 7, 2026, a ~38-day 13F lag). This quarter they opened Robinhood Markets Inc - A and trimmed Intel Corp. Their largest long position is Intel Corp at 8% of the equity book. They also disclosed $2.1M in put options (a bearish bet) and $16.1M in call options (bullish), shown separately below and excluded from the equity book. Cloning the disclosed picks since 2025 would be +43% (+27.5%/yr). That is a simulation of the disclosed long book, not audited returns.
The reported book (valued from quarter-end) returned +68.7%, a 25.6-point gap that is the cost of the ~38-day 13F disclosure lag a real follower can't avoid.
Growth of $10,000 cloning Persistent Asset Partners Ltd's disclosed long 13F book, rebalanced on each filing date (so it reflects each quarter's actual reporting lag, ~38 days for the latest filing, with no look-ahead), total-return basis (dividends reinvested), derived from end-of-day prices. “Their reported book” values the same picks from quarter-end, before they were public. S&P 500 is SPY total return over the same window. Excludes shorts, cash, options and non-13F holdings. Not investment advice.
Top-heavy: diversified book
Share of the disclosed book in its largest positions. A higher top-5 share means a more concentrated, higher-conviction portfolio.
96% mapped to company sectors
Direct operating-company sectors from our SIC-based security master. ETF/fund and unclassified holdings stay visible separately; this is not ETF look-through exposure.
Estimated $ traded · quarter-end prices, no cost basis
Other tracked managers holding the same core names as Persistent Asset Partners Ltd
| Manager / fund | Shared names | Their $ in those |
|---|---|---|
| MORGAN STANLEY | 77 / 80 | $62.3B |
| GOLDMAN SACHS GROUP INC | 77 / 80 | $37.5B |
| BlackRock, Inc. | 76 / 80 | $290.1B |
| BANK OF AMERICA CORP /DE/ | 76 / 80 | $41.5B |
| UBS Group AG | 76 / 80 | $22.8B |
| BARCLAYS PLC | 76 / 80 | $15.6B |
| WELLS FARGO & COMPANY/MN | 76 / 80 | $13.0B |
| CITIGROUP INC | 76 / 80 | $9.1B |
Ranked by how many of Persistent Asset Partners Ltd's top 80 disclosed names each fund also holds: a cross-fund conviction signal from the latest 13F of every tracked manager.
Bars show each stock's share of the portfolio. Click a row for its position history.
| # | Security | Value | Shares | % Port | Last move | History |
|---|---|---|---|---|---|---|
| 1 | Intel Corp COM | $24.2M | 173.1K | 7.6% | ▼−37% Reduced · −101K sh | |
| 2 | Robinhood MKTS Inc COM CL A | $19.2M | 191.1K | 6.0% | ▲New New position | |
| 3 | Stmicroelectronics N V NY REGISTRY | $16.9M | 225.6K | 5.3% | ▲New New position | |
| 4 | Amphenol Corp CL A | $13.3M | 75.5K | 4.2% | ▲New New position | |
| 5 | Seagate Technology HLDNGS PL ORD SHS | $8.9M | 9.3K | 2.8% | ▲New New position | |
| 6 | United Therapeutics Corp Del COM | $7.6M | 14.0K | 2.4% | ▲+103% Added · +7K sh | |
| 7 | Revolution Medicines Inc COM | $7.3M | 38.7K | 2.3% | ▲+49% Added · +13K sh | |
| 8 | Snowflake Inc COM SHS | $7.1M | 27.8K | 2.2% | ▲New New position | |
| 9 | Ford MTR Co COM | $6.2M | 445.8K | 2.0% | ▲New New position | |
| 10 | Abivax Sa SPONSORED ADS | $5.9M | 44.3K | 1.9% | ▲+94% Added · +21K sh | |
| 11 | Applied Matls Inc COM | $5.6M | 7.8K | 1.8% | ▲New New position | |
| 12 | Cogent Biosciences Inc COM | $5.4M | 138.3K | 1.7% | ▲+49% Added · +46K sh | |
| 13 | Kla Corp COM NEW | $5.0M | 16.4K | 1.6% | ▲New New position | |
| 14 | Biomarin Pharmaceutical Inc COM | $4.6M | 79.9K | 1.4% | ▲+113% Added · +42K sh | |
| 15 | Viking Therapeutics Inc COM | $4.4M | 112.7K | 1.4% | ▼−15% Reduced · −20K sh | |
| 16 | Cadence Design System Inc COM | $4.2M | 11.1K | 1.3% | ▲New New position | |
| 17 | Lam Research Corp COM NEW | $3.8M | 8.8K | 1.2% | ▲New New position | |
| 18 | Semtech Corp COM | $3.5M | 21.8K | 1.1% | ▼−30% Reduced · −10K sh | |
| 19 | Honeywell Intl Inc COM | $3.5M | 15.4K | 1.1% | ▲New New position | |
| 20 | Honeywell Aerospace Inc COM | $3.4M | 15.4K | 1.1% | ▲New New position | |
| 21 | Western Digital Corp COM | $3.1M | 4.9K | 1.0% | ▲New New position | |
| 22 | Sandisk Corp COM | $3.1M | 1.4K | 1.0% | ▼−90% Reduced · −13K sh | |
| 23 | Edgewise Therapeutics Inc COM | $2.8M | 69.4K | 0.9% | ▲+591% Added · +59K sh | |
| 24 | Littelfuse Inc COM | $2.7M | 5.9K | 0.9% | ▲New New position | |
| 25 | Corning Inc COM | $2.4M | 9.4K | 0.8% | ▼−84% Reduced · −50K sh | |
| 26 | Micron Technology Inc COM | $2.4M | 2.1K | 0.7% | ▼−88% Reduced · −14K sh | |
| 27 | Onto Innovation Inc COM | $2.3M | 5.9K | 0.7% | ▲New New position | |
| 28 | Kodiak Sciences Inc COM | $2.2M | 56.1K | 0.7% | ▲+9.2% Added · +5K sh | |
| 29 | Tripadvisor Inc COM | $2.2M | 158.5K | 0.7% | ▲+58% Added · +58K sh | |
| 30 | PDD Holdings Inc SPONSORED ADS | $2.1M | 28.1K | 0.7% | ▲+91% Added · +13K sh | |
| 31 | Advanced Energy Inds COM | $2.1M | 5.7K | 0.7% | ▲New New position | |
| 32 | Nexgen Energy Ltd COM | $2.1M | 226.7K | 0.7% | ▼−4.7% Reduced · −11K sh | |
| 33 | Eldorado Gold Corp New COM | $2.1M | 67.1K | 0.7% | ▲+28% Added · +15K sh | |
| 34 | Entegris Inc COM | $2.1M | 11.6K | 0.7% | ▲New New position | |
| 35 | Immunocore Hldgs PLC ADS | $2.1M | 65.2K | 0.7% | ▲+33% Added · +16K sh | |
| 36 | Precigen Inc COM | $2.0M | 355.8K | 0.6% | ▲25× Added · +342K sh | |
| 37 | Bitdeer Technologies Group CL A ORD SHS | $2.0M | 125.2K | 0.6% | ▲+35% Added · +32K sh | |
| 38 | Nebius Group N.V. SHS CLASS A | $2.0M | 7.2K | 0.6% | ▼−61% Reduced · −11K sh | |
| 39 | 4D Molecular Therapeutics In COM | $1.9M | 145.6K | 0.6% | ▲New New position | |
| 40 | Amcor PLC COM NEW | $1.9M | 42.9K | 0.6% | ▲+45% Added · +13K sh | |
| 41 | Navan Inc CL A | $1.8M | 79.8K | 0.6% | ▲New New position | |
| 42 | Arcus Biosciences Inc COM | $1.8M | 57.0K | 0.6% | ▼−5.2% Reduced · −3K sh | |
| 43 | MKS Inc. COM | $1.6M | 3.6K | 0.5% | ▲+588% Added · +3K sh | |
| 44 | Expand Energy Corporation COM | $1.5M | 17.2K | 0.5% | ▲+31% Added · +4K sh | |
| 45 | Trekor Metals Ltd COM | $1.5M | 214.3K | 0.5% | ▲New New position | |
| 46 | Torm PLC SHS CL A | $1.5M | 56.2K | 0.5% | ▲New New position | |
| 47 | Johnson & Johnson COM | $1.4M | 5.6K | 0.4% | ▼−59% Reduced · −8K sh | |
| 48 | Hudbay Minerals Inc COM | $1.4M | 59.0K | 0.4% | ▲New New position | |
| 49 | Cmb.tech NV SHS | $1.4M | 97.1K | 0.4% | ▼−13% Reduced · −14K sh | |
| 50 | Golar LNG Ltd SHS | $1.3M | 26.7K | 0.4% | ▲New New position |
The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.
This fund page is the Follow view. The Build view lets your agent pull holdings, quarter changes, overlap, and source filings through API or MCP.
curl -H "Authorization: Bearer YOUR_API_KEY" \ "https://arkolith.com/api/v1/funds/2056052/holdings"
Use Arkolith to show Persistent Asset Partners Ltd's latest holdings, largest changes, and filing provenance.
Put / call positions from the 13F — totals include every disclosed option leg
| Type | Underlying | Notional value | Underlying shares |
|---|---|---|---|
| CALL · bullish | VIKING THERAPEUTICS INCVKTX | $2.3M | 3K |
| CALL · bullish | ABIVAX SA-ADRABVX | $2.1M | 890 |
| CALL · bullish | CORCEPT THERAPEUTICS INCCORT | $1.6M | 524 |
| CALL · bullish | KYMERA THERAPEUTICS INCKYMR | $1.0M | 381 |
| CALL · bullish | UNIQURE NVQURE | $983K | 596 |
| CALL · bullish | SELLAS LIFE SCIENCES GROUP ISLS | $853K | 1K |
| CALL · bullish | CAPRICOR THERAPEUTICS INCCAPR | $697K | 831 |
| CALL · bullish | SUMMIT THERAPEUTICS INCSMMT | $520K | 2K |
| CALL · bullish | TENAX THERAPEUTICS INCTENX | $481K | 782 |
| CALL · bullish | ALUMIS INCALMS | $444K | 508 |
| CALL · bullish | BIOHAVEN LTDBHVN | $424K | 806 |
| PUT · bearish | CAPRICOR THERAPEUTICS INCCAPR | $405K | 1K |
| CALL · bullish | REPLIMUNE GROUP INCREPL | $397K | 2K |
| PUT · bearish | KODIAK SCIENCES INCKOD | $345K | 372 |
| CALL · bullish | BIOAGE LABS INCBIOA | $343K | 510 |
| CALL · bullish | CORVUS PHARMACEUTICALS INCCRVS | $274K | 340 |
| CALL · bullish | MONTE ROSA THERAPEUTICS INCGLUE | $258K | 434 |
| CALL · bullish | VAXCYTE INCPCVX | $249K | 135 |
| CALL · bullish | BRISTOL-MYERS SQUIBB COBMY | $244K | 2K |
| CALL · bullish | CORBUS PHARMACEUTICALS HOLDICRBP | $235K | 2K |
| CALL · bullish | KODIAK SCIENCES INCKOD | $216K | 502 |
| CALL · bullish | ANNEXON INCANNX | $207K | 897 |
| PUT · bearish | NOVO-NORDISK A/S-SPONS ADRNVO | $196K | 143 |
| CALL · bullish | EYEPOINT INCEYPT | $186K | 269 |
| CALL · bullish | HIMS & HERS HEALTH INCHIMS | $185K | 510 |
13F filers disclose option positions at the market value of the underlying the contracts reference, not the premium paid. A put is a bearish bet (it gains if the stock falls); a call is bullish. “Underlying shares” is the share count the contracts control, not a share holding. These legs are excluded from the equity book, weighting, concentration and sector figures above. Showing the largest 25 of 93 option legs.
As-of date vs the date the SEC received each filing
| Quarter | As of | Filed | Positions | Value | Form |
|---|---|---|---|---|---|
| Q2 2026 | Jun 30, 2026 | Aug 7, 2026 | 961 | $335.1M | 13F-HR |
| Q1 2026 | Mar 31, 2026 | May 12, 2026 | 388 | $268.3M | 13F-HR |
| Q4 2025 | Dec 31, 2025 | Feb 17, 2026 | 421 | $222.7M | 13F-HR |
| Q3 2025 | Sep 30, 2025 | Jan 15, 2026 | 287 | $145.5M | 13F-HR/A |
| Q2 2025 | Jun 30, 2025 | Aug 11, 2025 | 217 | $134.8M | 13F-HR |
| Q1 2025 | Mar 31, 2025 | May 13, 2025 | 200 | $119.2M | 13F-HR |
| Q4 2024 | Dec 31, 2024 | Feb 14, 2025 | 160 | $120.5M | 13F-HR |
Holdings from SEC EDGAR 13F-HR filings, updated quarterly, filed up to 45 days after quarter-end. Public domain. The book and weighting are long equity only; disclosed put/call options are listed separately and excluded from those totals. The performance line is a simulation of the disclosed long book, not an audited return.